Okay I've been sitting on this thread for a bit reading through everything and I want to weigh in because there's actually a lot of genuinely solid information getting passed around here mixed in with some things that need more scrutiny than they're getting.biohack_bella_87 wrote:I would 100% consider stacking with something that specifically does NOT hit the cortisol/prolactin pathways if I do this again - ipamorelin combo honestly makes sense from a harm reduction standpoint
First, bella, the writeup is legitimately useful and I don't want to be another GrumpyOldResearcher about the format. The cortisol piece being underemphasized relative to the GH hype is a real and persistent problem in how people discuss GHRP compounds and you documenting it with actual day counts and symptom specificity is exactly the kind of thing that saves someone else a rough week. The 3am waking as a cortisol rhythm disruption signal is something I've flagged to people repeatedly and they never believe it until it happens to them. Now there's a log they can read.
The ipamorelin stack suggestion at the end is correct and I'll add some texture to it since peptide_n00b asked about timing. In terms of injection timing if you're running ipa alongside hexarelin, same site or separate is less critical than making sure both are administered in a fasted state if you're going for the GH pulse. Fat and carbohydrates blunt the response considerably, so the fasting piece matters more than whether they're in the same syringe or not. A lot of people run them together without issue. I would personally keep them separate just for tracking purposes - if something feels off you want to be able to isolate variables and you cannot do that if everything is mixed. But that's my paranoid baseline position on basically everything, not a hard requirement.
This is correct and I want to pile onto it because peptide_n00b mentioned this came from "another thread" and I genuinely want them to be more suspicious of that. The connective tissue angle for hexarelin gets passed around in ways that are several inferential steps removed from what the actual research supports. The GH-mediated collagen synthesis argument has some plausibility as dr_peptide_curious correctly noted, but the leap from "hexarelin elevates GH which has downstream collagen synthesis implications" to "run hexarelin for your shoulder" is a long jump that passes over BPC-157 and TB-500 which have far more targeted and well-documented mechanisms for that specific application. Whoever told n00b to look at hexarelin for connective tissue recovery in another thread was either working from incomplete information or was oversimplifying in a way that can cost someone time and money on a suboptimal protocol.gainz_peptide_bro wrote:somebody steered you toward hexarelin for a shoulder injury and that steering is questionable. go find that thread and be skeptical of whoever said it lol
I hear you T_Ortega and the humor lands but I'm going to partially push back because dr_peptide_curious asking about the nature of the injury is not pearl-clutching, it's actually necessary. Tendinopathy versus partial tear versus chronic impingement with a postural component respond differently and the dosing approach and injection site considerations for BPC-157 specifically are not identical across those categories. Local versus systemic administration is a real decision point. So while yes, BPC-157 plus TB-500 is the correct broad directional answer, the "done, that's the thread" framing skips over stuff that matters.T_Ortega_Lifts wrote:The actual answer for n00b is what gainz already said - BPC-157 + TB-500, done. That's it. That's the thread.
That said, n00b, if your stress baseline is already elevated and you're not sleeping well, starting with something that hits the cortisol axis hard is genuinely inadvisable and I don't think multiple people saying that constitutes overcaution. The 3am waking that bella described is not fun on a good day. On a high-stress baseline it is a compounding problem that makes your recovery goal harder, not easier. Starting with ipa/CJC as a gentler on-ramp while running BPC-157 and TB-500 for the shoulder is not a wild suggestion, it's actually a pretty sensible layered approach.
One thing I want to flag that hasn't come up yet and that I am always suspicious about in these threads - n00b, how long have you been looking at this and where specifically did you source your information about hexarelin for connective tissue? Not asking to be hostile, asking because the quality of the initial recommendation shapes everything downstream and if you got steered toward a specific vendor's blend or a specific protocol from a source with obvious financial incentives you should know that before you spend money on anything.